Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Jaross

Showing results (71-80 of 92) with videos related to

Pageof 10
Sort By:
Atherosclerosis|June 1, 1980
Effects of p-chlorophenoxyisobutyric acid (CPIB) on the human liverM Hanefeld, C Kemmer, W Leonhardt, et al.
Atherosclerosis|October 1, 1995
Changes in epitope exposition of apolipoprotein A-I on the surface of high density lipoproteins after phospholipase A2 treatmentM Menschikowski, U Hempel, G Dinnebier, et al.
Thrombosis Research|September 7, 2000
Frequency of polymorphisms in the B-domain of factor V gene in APC-resistant patientsH Kostka, G Siegert, T Schwarz, et al.
Atherosclerosis|December 1, 1995
Secretory group II phospholipase A2 in human atherosclerotic plaquesM Menschikowski, M Kasper, P Lattke, et al.
Metabolism: Clinical and Experimental|May 31, 2002
Subclinical inflammation is strongly related to insulin resistance but not to impaired insulin secretion in a high risk population for diabetesT Temelkova-Kurktschiev, G Siegert, S Bergmann, et al.
Zeitschrift Fur Medizinische Laboratoriumsdiagnostik|January 1, 1987
[Apolipoprotein concentrations in cord blood in healthy neonates--comparison with adult reference values]S Bergmann, J J Heinrich, S Gehrisch, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|March 22, 2002
Pharmacokinetics and pharmacodynamics of fluvastatin in heart transplant recipients taking cyclosporine AJ W Park, R Siekmeier, P Lattke, et al.
Experimental and Clinical Endocrinology|September 1, 1989
Pathogenetic role of adipose tissue lipase deficit for development of hypertriglyceridaemiaU Julius, W Leonardt, D Noack, et al.
European Journal of Clinical Pharmacology|January 1, 1997
Effects of fluvastatin therapy on lipids, antioxidants, oxidation of low density lipoproteins and trace metalsW Leonhardt, T Kurktschiev, D Meissner, et al.
Arzneimittel-Forschung|April 1, 1990
Efficacy of a combined bezafibrate retard-colestyramine treatment in patients with hypercholesterolemiaS Fischer, M Hanefeld, P D Lang, et al.
Pageof 10

Showing results (71-80 of 92) with videos related to

Sort By:
Pageof 10
Atherosclerosis|June 1, 1980
Effects of p-chlorophenoxyisobutyric acid (CPIB) on the human liverM Hanefeld, C Kemmer, W Leonhardt, et al.
Atherosclerosis|October 1, 1995
Changes in epitope exposition of apolipoprotein A-I on the surface of high density lipoproteins after phospholipase A2 treatmentM Menschikowski, U Hempel, G Dinnebier, et al.
Thrombosis Research|September 7, 2000
Frequency of polymorphisms in the B-domain of factor V gene in APC-resistant patientsH Kostka, G Siegert, T Schwarz, et al.
Atherosclerosis|December 1, 1995
Secretory group II phospholipase A2 in human atherosclerotic plaquesM Menschikowski, M Kasper, P Lattke, et al.
Metabolism: Clinical and Experimental|May 31, 2002
Subclinical inflammation is strongly related to insulin resistance but not to impaired insulin secretion in a high risk population for diabetesT Temelkova-Kurktschiev, G Siegert, S Bergmann, et al.
Zeitschrift Fur Medizinische Laboratoriumsdiagnostik|January 1, 1987
[Apolipoprotein concentrations in cord blood in healthy neonates--comparison with adult reference values]S Bergmann, J J Heinrich, S Gehrisch, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|March 22, 2002
Pharmacokinetics and pharmacodynamics of fluvastatin in heart transplant recipients taking cyclosporine AJ W Park, R Siekmeier, P Lattke, et al.
Experimental and Clinical Endocrinology|September 1, 1989
Pathogenetic role of adipose tissue lipase deficit for development of hypertriglyceridaemiaU Julius, W Leonardt, D Noack, et al.
European Journal of Clinical Pharmacology|January 1, 1997
Effects of fluvastatin therapy on lipids, antioxidants, oxidation of low density lipoproteins and trace metalsW Leonhardt, T Kurktschiev, D Meissner, et al.
Arzneimittel-Forschung|April 1, 1990
Efficacy of a combined bezafibrate retard-colestyramine treatment in patients with hypercholesterolemiaS Fischer, M Hanefeld, P D Lang, et al.
Pageof 10